{
  "success": true,
  "pagesUsed": [
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "claude-opus-4-5",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "LY900018",
        "role": {
          "code": "Investigational Product",
          "codeSystem": "USDM",
          "decode": "Investigational Product"
        },
        "instanceType": "StudyIntervention",
        "description": "Nasal glucagon powder formulation for rescue treatment of hypoglycemia, synthetic single-chain 29-amino-acid polypeptide identical to human glucagon",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "GlucaGen",
        "role": {
          "code": "Comparator",
          "codeSystem": "USDM",
          "decode": "Comparator"
        },
        "instanceType": "StudyIntervention",
        "description": "Intramuscular glucagon injection, currently approved product requiring reconstitution prior to administration",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Human Regular Insulin",
        "role": {
          "code": "Concomitant Medication",
          "codeSystem": "USDM",
          "decode": "Concomitant Medication"
        },
        "instanceType": "StudyIntervention",
        "description": "IV infusion used to induce hypoglycemia during the study procedure",
        "productIds": [
          "prod_3"
        ],
        "administrationIds": [
          "admin_3"
        ]
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "LY900018 nasal powder",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Powder",
          "codeSystem": "USDM",
          "decode": "Powder"
        },
        "strength": "3 mg glucagon",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "id": "prod_2",
        "name": "GlucaGen",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Powder",
          "codeSystem": "USDM",
          "decode": "Powder"
        },
        "strength": "1 mg glucagon",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "id": "prod_3",
        "name": "Human Regular Insulin (diluted)",
        "instanceType": "AdministrableProduct",
        "doseForm": {
          "code": "Solution",
          "codeSystem": "USDM",
          "decode": "Solution"
        },
        "strength": "0.3 U/mL"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "LY900018 3 mg nasal single dose",
        "instanceType": "Administration",
        "dose": "3 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intranasal",
          "codeSystem": "USDM",
          "decode": "Intranasal"
        },
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "id": "admin_2",
        "name": "GlucaGen 1 mg intramuscular single dose",
        "instanceType": "Administration",
        "dose": "1 mg",
        "doseFrequency": "Single dose",
        "route": {
          "code": "Intramuscular",
          "codeSystem": "USDM",
          "decode": "Intramuscular"
        },
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "id": "admin_3",
        "name": "Human Regular Insulin IV infusion for hypoglycemia induction",
        "instanceType": "Administration",
        "dose": "2 mU/kg/min (adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM)",
        "doseFrequency": "Continuous infusion until PG <60 mg/dL",
        "route": {
          "code": "Intravenous",
          "codeSystem": "USDM",
          "decode": "Intravenous"
        },
        "duration": "Until target plasma glucose level achieved (maximum 4 hours)"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "Glucagon",
        "instanceType": "Substance",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon, active pharmaceutical ingredient in LY900018 and GlucaGen"
      },
      {
        "id": "sub_2",
        "name": "Human Regular Insulin",
        "instanceType": "Substance",
        "description": "Used to induce hypoglycemia during study procedure"
      }
    ],
    "medicalDevices": [
      {
        "id": "dev_1",
        "name": "Nasal dosing device",
        "instanceType": "MedicalDevice",
        "manufacturer": "Eli Lilly and Company"
      }
    ],
    "summary": {
      "interventionCount": 3,
      "productCount": 3,
      "deviceCount": 1
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "LY900018",
        "role": "Investigational Product",
        "description": "Nasal glucagon powder formulation for rescue treatment of hypoglycemia, synthetic single-chain 29-amino-acid polypeptide identical to human glucagon"
      },
      {
        "name": "GlucaGen",
        "role": "Comparator",
        "description": "Intramuscular glucagon injection, currently approved product requiring reconstitution prior to administration"
      },
      {
        "name": "Human Regular Insulin",
        "role": "Concomitant Medication",
        "description": "IV infusion used to induce hypoglycemia during the study procedure"
      }
    ],
    "products": [
      {
        "name": "LY900018 nasal powder",
        "doseForm": "Dry powder",
        "strength": "3 mg glucagon",
        "manufacturer": "Eli Lilly and Company"
      },
      {
        "name": "GlucaGen",
        "doseForm": "Dry powder for reconstitution",
        "strength": "1 mg glucagon",
        "manufacturer": "Novo Nordisk A/S"
      },
      {
        "name": "Human Regular Insulin (diluted)",
        "doseForm": "Solution for infusion",
        "strength": "0.3 U/mL",
        "manufacturer": null
      }
    ],
    "substances": [
      {
        "name": "Glucagon",
        "description": "Synthetic single-chain, 29-amino-acid polypeptide identical to human glucagon, active pharmaceutical ingredient in LY900018 and GlucaGen"
      },
      {
        "name": "Human Regular Insulin",
        "description": "Used to induce hypoglycemia during study procedure"
      }
    ],
    "administrations": [
      {
        "name": "LY900018 3 mg nasal single dose",
        "dose": "3 mg",
        "frequency": "Single dose",
        "route": "Intranasal",
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "name": "GlucaGen 1 mg intramuscular single dose",
        "dose": "1 mg",
        "frequency": "Single dose",
        "route": "Intramuscular",
        "duration": "Single administration upon hypoglycemia onset"
      },
      {
        "name": "Human Regular Insulin IV infusion for hypoglycemia induction",
        "dose": "2 mU/kg/min (adjustable up to 3 mU/kg/min for T1DM or 4 mU/kg/min for T2DM)",
        "frequency": "Continuous infusion until PG <60 mg/dL",
        "route": "Intravenous",
        "duration": "Until target plasma glucose level achieved (maximum 4 hours)"
      }
    ],
    "devices": [
      {
        "name": "Nasal dosing device",
        "manufacturer": "Eli Lilly and Company",
        "purpose": "Single-use nasal delivery device for LY900018 glucagon powder administration"
      }
    ]
  }
}